Velmanase Alfa

Records for this ingredient, by country (identity only).

ATC A16AB15 · 5 markets · 5 records

Velmanase Alfa 5 markets · 5 records Forms

Filters

MarketGB 1 AU 1 HK 1 EU 1 FR 1

Strength

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

10 mg per mL / per unit basis not statedinjectionLamzede 10mg powder for solution for infusion vials

AU 1 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

10 mg per mL / per unit basis not statedinjectionLAMZEDE velmanase alfa 10 mg powder for injection vial unknown

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名LAMZEDE POWDER FOR SOLUTION FOR INFUSION 10MG/VIAL ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Lamzede ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

10 mg per mL / per unit basis not statedinjectionLAMZEDE 10 mg, poudre pour solution pour perfusion

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	GB	AU	HK	EU	FR
10 mg per mL / per unit basis not stated cannot compare injection	Lamzede 10mg powder for solution for infusion vials	LAMZEDE velmanase alfa 10 mg powder for injection vial	not recorded	not recorded	LAMZEDE 10 mg, poudre pour solution pour perfusion
not disclosed unknown	not recorded	not recorded	LAMZEDE POWDER FOR SOLUTION FOR INFUSION 10MG/VIAL	Lamzede	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录（未在本表显示）。另有 1 個規格/劑型僅在 HK · EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.